Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san francisco blog main
san francisco top stories
5
×
biotech
fda
national top stories
boston blog main
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
auris health
biogen
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
intuitive surgical
johnson & johnson
roboticsai
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
akouos
alex azar
alex gorsky
allergan
alliance for aging research
What
plans
5
×
announced
cash
company
deal
medical
acquiring
acquisitions
administration
angry
anti
area
auris
based
bay
benefited
billion
bio
biopsy
blood
buildout
builds
buy
cancer
ceo
clearance
close
collabs
company’s
covid
crunch
daniel
despite
developer
developing
didn’t
drug
end
fda
fear
Language
unset
Current search:
plans
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans